FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
- Details
- Category: FDA

FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
- Details
- Category: FDA

FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
- Details
- Category: FDA

FDA approves first oral GLP-1 treatment for type 2 diabetes
- Details
- Category: FDA

FDA takes first action under new international collaboration with Australia and Canada
- Details
- Category: FDA

FDA approves first treatment for patients with rare type of lung disease
- Details
- Category: FDA

EMA/FDA analysis shows high degree of alignment in marketing application decisions between EU and US
- Details
- Category: EMA

More Pharma News ...
- FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
- FDA approves first therapy for rare joint tumor
- FDA approves first treatment for severe hypoglycemia that can be administered without an injection
- FDA approves first generics of Lyrica
- FDA approves new treatment for refractory multiple myeloma
- FDA approves first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system
- FDA seeks public feedback on new drug approval transparency efforts